MDRTB
States must invest in R&D to fund new drug discoveries: TB AllianceGeneric manufacturers are essential players in the fight to end TB so we do speak with generic manufacturers as part of our access strategy.
Price of J&J’s TB drug to drop by more than halfLife-saving drug bedaquiline by US pharma company Johnson & Johnson (J&J) is now being offered at $400 per patient —over 50% cheaper than t...
New J&J TB drug not without side effects: Sir John WalkerThe 1997 Nobel winner in chemistry, who was one of the speakers at the Lindau Nobel Laureates meeting, said clinical data showed that the d...
Drug to treat MDRTB to be made available across the country: GovernmentUnion Health Minister J P Nadda, in a written reply, said that the states are being prepared to monitor the treatment of patients with Beda...
2.1 million cases of tuberculosis in India annuallyHealth MInister J.P. Nadda said that the vast majority of the population infected with the bacteria have "latent TB infection rather than T...
TB patients in India: WHO stresses on need to improve treatment, but heath ministry says all fineThe WHO reckons India needs to improve diagnosis and treatment of patients to shrug off the lethal distinction of being the world's TB capi...
Load More